Research.

Researchers show that a quick nasal swab can pick up early biological changes linked to Alzheimer’s, even before thinking and memory problems appear.

  • AmidFuror@fedia.io
    link
    fedilink
    arrow-up
    0
    ·
    15 days ago

    For those who didn’t read the article, they ask patients to insert a nasal swab into either nostril for 5 minutes. Meanwhile they have you fill out a questionnaire. Once complete, you are free to leave.

    Any patient who walks out of the office with the swab still jammed up their nose is likely to be developing Alzheimer’s.

    • dustycups@aussie.zone
      link
      fedilink
      English
      arrow-up
      0
      ·
      15 days ago

      Thank you for saving me from reading the article.
      I also found a nasal swab up my nose, but that is from an unrelated drinking problem.

    • Dunning Kruger@lemmy.world
      link
      fedilink
      English
      arrow-up
      0
      ·
      14 days ago

      Well, good job, dude.

      A completely made-up response “for those who didn’t read the article,” and it continues to be upvoted.

      I posted what the article actually says and no one cares.

      AmidFuror: 1 ; Faith in humanity: 0

  • Dunning Kruger@lemmy.world
    link
    fedilink
    English
    arrow-up
    0
    ·
    14 days ago

    The procedure to collect nasal cells took just a few minutes. After applying a numbing spray, a clinician guides a tiny brush into the upper part of the nose where smell-detecting nerve cells live. Researchers then study the collected cells to see which genes are active, a sign of what’s happening inside the brain.

    The study compared samples from 22 participants, measuring the activity of thousands of genes across hundreds of thousands of individual cells, amounting to millions of data points. The nasal swab was able to pick up early shifts in nerve and immune cells. This includes people who showed lab-based signs of Alzheimer’s but had no symptoms yet.

    A combined nose tissue gene score correctly separated early and clinical Alzheimer’s from healthy controls about 81% of the time.